Autolus Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 298
Employees
  • Stock Symbol
  • AUTL
Stock Symbol
  • Share Price
  • $10.28
  • (As of Monday Closing)

Autolus General Information

Description

Autolus Therapeutics PLC is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and others.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • The Mediaworks, 191 Wood Lane
  • White City
  • London W12 7RZ
  • England, United Kingdom
+44 020 0000 0000

Autolus Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Autolus Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.28 $10.89 $3.00 - $17.19 $538M 52.3M 72.9K -$2.86

Autolus Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 30-Sep-2018 FY 2017 30-Sep-2017
EV 424,368 391,090 1,094,451
Revenue 3,150 2,908 1,407 1,693
EBITDA (159,542) (136,939) (51,854) (22,455)
Net Income (140,177) (123,849) (44,751) (19,727)
Total Assets 317,077 303,533 273,205 148,662
Total Debt 52,869 26,221 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Autolus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Autolus‘s full profile, request access.

Request a free trial

Autolus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Autolus Therapeutics PLC is a biopharmaceutical company. It is engaged in the development of next-generation programmed
Biotechnology
London, United Kingdom
298 As of 2019
00000
00000000000 00000

0000000

onsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut en
0000 000000000
San Diego, CA
00 As of 0000
00000
0000000000 0 00000

0000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud e
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Autolus Competitors (59)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genelux Venture Capital-Backed San Diego, CA 00 00000 0000000000 0 00000
0000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
000000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 00000 00000000000 00000
0000000000 0000000 Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 00000 00000000000 00000
00000000 Formerly VC-backed Tübingen, Germany 000 00000 000000000000 00000
You’re viewing 5 of 59 competitors. Get the full list »

Autolus Executive Team (13)

Name Title Board Seat Contact Info
Christian Itin Ph.D Chief Executive Officer & Chairman
Andrew Oakley Chief Financial Officer, Finance & Senior Vice President
Christopher Vann Chief Operating Officer, Operations & Senior Vice President
Martin Pule Founder, Board Member, Senior Vice President & Chief Scientific Officer
Chris Williams Ph.D Director, Business Development & Board Member
You’re viewing 5 of 13 executive team members. Get the full list »

Autolus Board Members (11)

Name Representing Role Since
Chris Williams Ph.D Autolus Director, Business Development & Board Member 000 0000
Christian Itin Ph.D Autolus Chief Executive Officer & Chairman 000 0000
Cynthia Butitta Autolus Board Member 000 0000
Jay Backstrom MD Autolus Board Member 000 0000
John Berriman Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Autolus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Autolus Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Autolus‘s full profile, request access.

Request a free trial